L-Carnitine L-Tartrate (LCLT): Exercise Recovery, Muscle Damage & Androgen Receptors

Evidence: Moderate (Volek-lab RCTs · exercise recovery · muscle damage · insulin receptor upregulation)

⚡ 60-Second Summary

L-Carnitine L-Tartrate (LCLT) is a specific salt form of L-carnitine with faster absorption kinetics than free-form carnitine. Its primary use case in sports nutrition is exercise recovery — reducing post-exercise muscle damage markers (creatine kinase, myoglobin) and soreness. A series of well-designed studies by Jeff Volek and colleagues at the University of Connecticut also found that LCLT upregulates androgen receptor density in muscle after resistance exercise, potentially enhancing the anabolic signaling of testosterone.

Standard dose: 2–4 g/day taken around exercise, ideally with an insulin-stimulating meal or shake to enhance carnitine transport into muscle. Part of the broader carnitine family — see the L-Carnitine overview page for full context including TMAO considerations.

What is L-Carnitine L-Tartrate?

LCLT is produced by combining L-carnitine with tartaric acid (L-tartrate), a naturally occurring organic acid found in grapes and wine. The resulting salt is more stable in powder form and absorbed somewhat faster than free-form L-carnitine, with peak plasma concentrations appearing approximately 30–45 minutes sooner in pharmacokinetic studies.

LCLT contains roughly 68% L-carnitine by weight (with tartrate making up the remainder), so a 3 g dose of LCLT delivers approximately 2 g of elemental L-carnitine. This is important to note when comparing doses across studies that use different carnitine forms.

The research base for LCLT as a specifically exercise-recovery-focused carnitine form is largely attributable to a series of studies from Jeff Volek's laboratory at the University of Connecticut (now at Ohio State University), published predominantly in the American Journal of Physiology and Journal of Strength and Conditioning Research.

Evidence-based benefits of LCLT

1. Post-exercise muscle damage reduction

The clearest finding from LCLT trials is attenuation of exercise-induced muscle damage markers. Volek et al. (2002) found that 2 g/day LCLT for 3 weeks significantly reduced creatine kinase (CK) and myoglobin levels after acute resistance exercise compared to placebo. These are markers of muscle fiber disruption. Reduced CK and myoglobin post-exercise is associated with faster functional recovery and reduced muscle soreness — an effect consistent with carnitine's role in buffering exercise-induced reactive oxygen species that contribute to muscle membrane damage.

2. Androgen receptor upregulation

This is the most discussed (and most novel) LCLT finding. Volek et al. (2002) measured androgen receptor content in vastus lateralis muscle biopsies and found that LCLT supplementation increased androgen receptor density following acute resistance exercise. The proposed mechanism: carnitine's antioxidant role protects androgen receptors (which are redox-sensitive) from oxidative degradation during exercise. More androgen receptors means more sites for testosterone (which spikes post-exercise) to bind and exert anabolic signaling. Whether this translates to meaningfully greater muscle hypertrophy over time has not been definitively established in longer trials, but the mechanism is biologically plausible.

3. Insulin sensitivity and carnitine transport

Stephens et al. (2006, 2013) at the University of Nottingham showed that muscle carnitine content can be meaningfully increased with oral supplementation, but only when combined with insulin-mediated uptake — specifically, consuming LCLT with 80–94 g of carbohydrate significantly increased muscle carnitine concentration, whereas carnitine alone did not. This work established that glucose/insulin co-administration is important for skeletal muscle carnitine loading, explaining why many LCLT protocols recommend taking it with carbohydrate-containing meals or post-workout nutrition.

4. Hypoxia and blood flow support (moderate evidence)

Some evidence suggests carnitine (including LCLT) may improve oxygen utilization in hypoxic conditions and support blood flow by reducing exercise-induced free radical damage to endothelial cells. This is speculative for performance enhancement but consistent with carnitine's established mitochondrial function.

The androgen receptor story: what the evidence actually says

The Volek et al. androgen receptor findings have been widely cited in supplement marketing and are genuinely interesting mechanistically. Key nuances:

These caveats do not make the research wrong — they contextualize how confident to be in translating a surrogate marker to a real-world outcome.

LCLT vs other carnitine forms

Form Primary use Carnitine content Relative absorption speed
L-Carnitine L-Tartrate (LCLT) Exercise recovery, muscle damage, androgen receptors ~68% L-carnitine Fast (peak ~45–60 min)
Free-form L-Carnitine Clinical deficiency, fat oxidation ~100% Moderate (peak ~75 min)
Acetyl-L-Carnitine (ALCAR) Cognitive support, neuroprotection ~68% L-carnitine equivalent Fast, blood-brain barrier penetrant
Propionyl-L-Carnitine Peripheral vascular disease ~42% L-carnitine equivalent Moderate

How much LCLT should you take?

Safety and side effects

LCLT inherits L-carnitine's favorable safety profile. At 2–4 g/day:

Drug and nutrient interactions

Check our free interaction checker for additional combinations.

Who might benefit — and who shouldn't

Most likely to benefitUnlikely to benefit
Resistance-trained individuals seeking faster recovery between sessions Aerobic endurance athletes (ALCAR or free-form carnitine may be more appropriate)
Older men (≥40) using testosterone optimization strategies People avoiding carbohydrates (insulin needed for muscle carnitine loading)
Those experiencing significant exercise-induced muscle damage Vegans with TMAO concerns (though risk at 2–4 g/day is not established)
Athletes in high-volume training blocks with compressed recovery windows Casual exercisers without specific recovery problems

Frequently asked questions

What is LCLT and how is it different from regular L-carnitine?

LCLT is L-carnitine bound to tartaric acid — a faster-absorbing salt form. It contains about 68% L-carnitine by weight. Regular L-carnitine is the pure free form or in liquid as carnitine base. LCLT's faster absorption and the specific Volek-lab research on exercise recovery and androgen receptors distinguish it from general-purpose carnitine supplementation.

How does LCLT upregulate androgen receptors?

The leading hypothesis is that carnitine's antioxidant activity during exercise preserves androgen receptor integrity by reducing oxidative receptor degradation. More intact androgen receptors mean more binding sites for post-exercise testosterone surges. This is mechanistically plausible but extrapolating to guaranteed muscle gains requires longer trials than currently exist.

Do I need carbohydrates with LCLT?

For maximizing muscle carnitine loading, yes — the Stephens et al. studies showed that carnitine uptake into skeletal muscle requires insulin-mediated transport, which is stimulated by carbohydrate intake. Taking LCLT with a carb-containing meal or post-workout shake is therefore recommended. If you're on a very low-carb diet, carnitine loading in muscle will be less efficient.

What dose of LCLT should I take?

2 g/day (the Volek et al. protocol) to 4 g/day covers the range studied. Since LCLT is ~68% carnitine, 3 g LCLT provides roughly 2 g elemental carnitine — a standard benchmark. Take it with a meal that includes carbohydrates.


Related ingredients and articles

Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.